Catheter Precision, Inc. filed an 8-K on May 30, 2025, reporting that the ownership interest of current investors will be diluted, as the net tangible book value per share will decrease post-stock issuance to $(0.95) per share, with a $1.25 dilution for new investors at an assumed offering price of $0.30.